Work on telehealth flexibility issues concerning the Public Health Emergency. Also work on legislative matters pertaining to across-the-board spending cuts including, S. 748, the Medicare Sequester Relief Act; and HR 1868.
Work on increased funding for the Provider Relief Fund program as proposed under HR 1319, the American Rescue Plan of 2021.
Duration: November 1, 2013
to
January 1, 2022
General Issues: Medicare/Medicaid , Disaster Planning/Emergencies , Health Issues , Budget/Appropriations , Taxation/Internal Revenue Code
Spending: about $550,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Diane Major Mrs. Health Policy Analyst for Sen. Repub. Policy Com.
Health Leg. Assistant for Sen. Craig Thomas
Professional Staff Member for Com on Gov't Operations
Health Leg. Assistant for Rep. Craig Thomas
Diane Major Health Policy Analyst for Senate Republican Policy Committee
Health Policy Analyst for Senate Republican Policy Com't
Health Policy Analyst for Sen. Repub. Policy Com.
Health Leg. Assistant for Sen. Craig Thomas
Professional Staff Member for Com. on Gov't Ops
Health Leg. Assistant for Rep. Craig Thomas
Health Policy Analyst for Sen. Repub. Policy Com't.
Brenda Reese Conference Coordinator for House Republican Conference
Conference Coordinator for House Repub. Conf.
Assistant to Assistant Sec. of Gov't Affairs DOT
Scheduler for Rep. Mickey Edwards
Conference Coordinator for House Republican Conf.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2022
The D Major Group terminated an engagement in which they represented University Hospitals Health System Inc. on April 19, 2022.
Original Filing: 301363386.xml
4th Quarter, 2021
In Q4, The D Major Group did no lobbying for University Hospitals Health System Inc. . The report was filed on Jan. 17, 2022.
Original Filing: 301323892.xml
3rd Quarter, 2021
In Q3, The D Major Group did no lobbying for University Hospitals Health System Inc. . The report was filed on Oct. 17, 2021.
Original Filing: 301300893.xml
2nd Quarter, 2021
In Q2, The D Major Group did no lobbying for University Hospitals Health System Inc. . The report was filed on July 18, 2021.
Original Filing: 301279418.xml
1st Quarter, 2021
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 18, 2021.
Original Filing: 301255689.xml
Lobbying Issues
Work on telehealth flexibility issues concerning the Public Health Emergency. Also work on legislative matters pertaining to across-the-board spending cuts including, S. 748, the Medicare Sequester Relief Act; and HR 1868.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on increased funding for the Provider Relief Fund program as proposed under HR 1319, the American Rescue Plan of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2020
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233887.xml
Lobbying Issues
Work on implementation issues stemming from S. 3548, the Coronavirus Aid Relief and Economic Security (CARES) Act. The includes telehealth, Medicare Accelerated Payments, the Provider Relief Fund and Medicare sequestration. In addition, work on disproportionate share hospital payment matters as extended in HR 133, the Consolidated Appropriations Act of 2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical surprise billing reform proposals included in HR 133, the Consolidated Appropriations Act of 2021. Also, monitor and work on emergency use authorizations related to innovative COVID therapeutic therapies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor federal funding levels concerning NIH, SAMSHA, ASPR, and other public health provisions as included in HR 133, the Consolidated Appropriations Act of 2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor emergency preparedness planning issues related to regional readiness and other specialty response.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2020
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Oct. 16, 2020.
Original Filing: 301212158.xml
Lobbying Issues
Work on implementation issues stemming from S. 3548, the Coronavirus Aid Relief and Economic Security (CARES) Act. Also, work on Medicare Accelerated and Advance Payment provisions included in HR 8337, the Continuing Appropriations Act of 2021, and Other Extensions Act. In addition, work on disproportionate share hospital payment matters, innovative value-based care payment models including accountable care organizations, end-stage-renal disease and children's hospital issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor federal funding levels concerning NIH, SAMSHA, ASPR, and other health provisions as included in HR 8337, the Continuing Appropriations Act of 2021, and Other Extensions Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor emergency preparedness planning issues related to physician workforce and other specialty response providers.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2020
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301192468.xml
Lobbying Issues
Work on implementation issues stemming from S. 3548, the Coronavirus Aid Relief and Economic Security Act. In addition, work on disproportionate share hospital payment matters, innovative value-based care payment models including accountable care organizations, end-stage-renal disease and children's hospital issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor federal funding levels concerning NIH, SAMSHA, ASPR and FDA as related to FY2021 appropriations matters.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor emergency preparedness planning issues related to physician workforce and other specialty response providers.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2020
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 18, 2020.
Original Filing: 301171690.xml
Lobbying Issues
Work on disproportionate share hospital payment proposals, including those extended in S. 3548, the Coronavirus Aid Relief and Economic Security Act. In addition, work on innovative value-based care payment models including accountable care organizations, end-stage-renal disease and children's hospital issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor federal funding levels concerning NIH, SAMSHA, ASPR and FDA as related to FY2021 appropriations matters.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Worked on health care provider relief support as related to H.R.6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; H.R.6201, the Families First Coronavirus Response Act; and S. 3548 the Coronavirus Aid, Relief, and Economic Security Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2019
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Jan. 12, 2020.
Original Filing: 301104554.xml
Lobbying Issues
Work on disproportionate share hospital payment proposals, including those extended in H.R. 1865, the Further Consolidated Appropriations Act of 2020. In addition, work on innovative value-based care payment models including accountable care organizations and quality measurement updates. Also, work on children's hospital issues related to bed size flexibility.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for increased NIH funding and specifically, Alzheimer's research and other brain health initiatives as included in HR 1865, the Further Consolidated Appropriations Act of 2020.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Oct. 16, 2019.
Original Filing: 301067206.xml
Lobbying Issues
Monitor disproportionate share hospital payment proposals, including H.R. 2328, The Community Health Investment, Modernization and Excellence Act of 2019. In addition, work on innovative value-based care payment models including accountable care organizations and quality measurement updates. Also, work on children's hospital issues related to bed size flexibility.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for increased NIH funding and specifically, Alzheimer's research and other brain health initiatives as included in HR 2740, The FY 2020 Labor, HHS, Education and Related Agencies Appropriations bill.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on July 14, 2019.
Original Filing: 301045446.xml
Lobbying Issues
Monitor disproportionate share hospital payment proposals, including H.R. 2328, The Community Health Investment, Modernization and Excellence Act of 2019. In addition, work on innovative value-based care payment models including accountable care organizations and quality measurement updates. Also, work on children's hospital issues related to bed size flexibility.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including S. 1895, The Lower Health Care Costs Act; and HR 3630, The No Surprises Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for increased NIH funding and specifically, Alzheimer's research and other brain health initiatives as included in HR 2740, The FY 2020 Labor, HHS, Education and Related Agencies Appropriations bill.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 14, 2019.
Original Filing: 301025011.xml
Lobbying Issues
Engage with policymakers on uncompensated care issues, including disproportionate share hospital payments. In addition, work on innovative value-based care payment models -- specifically, accountable care organizations. Also, work on children's hospital issues related to bed size flexibility.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor medical billing reform proposals, including industry best practices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for increased NIH funding and specifically, Alzheimer's research and other brain health initiatives.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Jan. 14, 2019.
Original Filing: 301004359.xml
Lobbying Issues
Engage with policymakers on integrated health system payment matters related to value based care, accountable care organizations, site neutrality and medication assistance programs for low-income and vulnerable populations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor public health issues related to pandemic preparedness, maternal health and opioid treatment that contain provider-based provisions. Specifically, this includes HR 1318, Preventing Maternal Deaths Act; HR 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and HR 6, the Substance Use Disorder Prevention that Promotes Opioid Recover and Treatment (SUPPORT) for Patients and Communities Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections affecting non-profit organizations as included in HR 1, the "Tax Cuts and Jobs Act."
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitor NIH, SAMHSA and CDC funding in HR 6157, the Department of Defense and Labor, Health and Human Services and Education Appropriations Act, 2019 and Continuing Appropriations Act 2019.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987815.xml
Lobbying Issues
Engage with policymakers on integrated hospital system issues, including accountable care organizations, medication assistance programs for low-income and vulnerable populations, and site neutrality provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on hospital system reforms such as value based care. Also, monitor provider-based provisions related to HR 6, the Substance Use Disorder Prevention that Promotes Opioid Recover and Treatment (SUPPORT) for Patients and Communities Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections affecting non-profit organizations as included in HR 1, the "Tax Cuts and Jobs Act."
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Monitor NIH, SAMHSA and CDC funding in HR 6157, the Department of Defense and Labor, Health and Human Services and Education Appropriations Act, 2019 and Continuing Appropriations Act 2019.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on July 17, 2018.
Original Filing: 300967079.xml
Lobbying Issues
Engage with policymakers on integrated hospital system issues, including accountable care organizations. Advocate for preservation of provider-based medication assistance programs for low-income and vulnerable populations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on hospital system reforms such as value based care. Also, monitor potential provider reporting requirements and other policy changes related to substance abuse legislation as outlined in the Helping End Addiction and Lessen (HEAL) Substance Use Disorders Act; and the Opioid Crisis Response Act (S. 2680).In addition, monitor increased NIH funding levels.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections affecting non-profit organizations as included in HR 1, the "Tax Cuts and Jobs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 14, 2018.
Original Filing: 300944749.xml
Lobbying Issues
Engage with policymakers on integrated hospital system issues, including accountable care organizations. Advocate for children's health insurance funding and Medicare payment extenders as reauthorized under HR 1892, the Bipartisan Budget Act of 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on hospital system reforms such as value based care. In addition, monitor increased NIH funding and other provider based grants as related to HR 1625, the Consolidated Appropriations Act of 2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections affecting non-profit organizations as included in HR 1, the "Tax Cuts and Jobs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Jan. 12, 2018.
Original Filing: 300923505.xml
Lobbying Issues
Engage with policymakers on integrated hospital system issues, including accountable care organizations. Advocate for funding extension related to S. 1827, the "Keep Kids' Insurance Dependable and Secure Act of 2017;" and HR 3921, the "HEALTHY Kids Act." Monitor funding provisions associated with the Medicare Extenders package and S. 870, the "Chronic Care Act of 2017."
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on hospital system reforms such as value based care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for the preservation of the New Market Tax Credit, private activity bonds and other proposed changes affecting non-profit organizations included in HR 1, the "Tax Cuts and Jobs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $18,000. The report was filed on Oct. 20, 2017.
Original Filing: 300916862.xml
Lobbying Issues
Engage with policymakers on integrated hospital system issues, including accountable care organizations.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on uncompensated care issues and other hospital system related reforms as included in HR 1628, the American Health Care Act of 2017, and the Better Care Reconciliation Act of 2017.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $18,000. The report was filed on July 16, 2017.
Original Filing: 300885268.xml
Lobbying Issues
Engage with policymakers on uncompensated care issues and other hospital system related reforms. This includes matters contained in H.R. 1628, the American Health Care Act of 2017, and the Better Care Reconciliation Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for improved drug discovery policies for breakthrough medicines, including NIH funding.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $18,000. The report was filed on April 14, 2017.
Original Filing: 300865820.xml
Lobbying Issues
Engage with policymakers on uncompensated care issues and other related health reform changes. This includes H.R. 1628, the American Health Care Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for improved drug discovery policies for breakthrough medicines. This includes adequate NIH funding.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $18,000. The report was filed on Jan. 16, 2017.
Original Filing: 300846935.xml
Lobbying Issues
Physician and hospital payment policy matters, including treatment of outpatient facilities under development and recognition of innovative cancer care treatment therapies. Monitor H.R. 34, the "21st Century Cures Act."
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning medical research funding related to innovative drug discovery strategies as contained in H.R. 34, the 21st Century Cures Act; and H.R. 2028, the "Further Continuing & Security Assistance Appropriations Act of 2017."
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $18,000. The report was filed on Oct. 19, 2016.
Original Filing: 300831846.xml
Lobbying Issues
Physician and hospital payment policy matters, including treatment of outpatient facilities under development as well as recognition of innovative cancer care treatment therapies, including HR 5273, The Helping Hospitals Improve Patient Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning medical research funding as it relates to innovative drug discovery strategies. Also, monitor mental health and substance abuse policy matters.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on July 16, 2016.
Original Filing: 300810929.xml
Lobbying Issues
Physician and hospital payment policy matters, including treatment of outpatient facilities under development as well as recognition of innovative cancer care treatment therapies, including HR 5273, The Helping Hospitals Improve Patient Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning NIH research funding as it relates to cancer care. Also, monitor mental health and substance abuse policy matters.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 19, 2016.
Original Filing: 300794573.xml
Lobbying Issues
Physician and hospital payment policy matters, including treatment of outpatient facilities under development as well as recognition of innovative cancer care treatment therapies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning NIH research funding as it relates to cancer care. Also, monitor mental health and substance abuse policy matters.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Jan. 14, 2016.
Original Filing: 300772301.xml
Lobbying Issues
Physician and hospital payment policy matters, including treatment of outpatient facilities under development as well as recognition of innovative cancer care treatment therapies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Hospital issues related to HR 2029, the Consolidated Appropriations Act of 2016.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753882.xml
Lobbying Issues
Physician and hospital payment policy matters, including recognition of industry leading innovative cancer care treatment therapies.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on July 13, 2015.
Original Filing: 300733288.xml
Lobbying Issues
Physician and hospital payment policy matters, including H.R. 2, the Medicare Access & CHIP Reauthorization Act of 2015; and H.R. 6, the 21st Century Cures Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on April 16, 2015.
Original Filing: 300717896.xml
Lobbying Issues
Physician and hospital payment policy matters, including H.R. 2, the Medicare Access & CHIP Reauthorization Act of 2015.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $10,000. The report was filed on Jan. 17, 2015.
Original Filing: 300699356.xml
Lobbying Issues
Inpatient hospital issues, including cancer care for patients, related to H.R. 83, the Consolidated & Further Continuing Appropriations Act of 2015; and the Hospital Improvements for Payment Act of 2014 (discussion draft).
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
The D Major Group amended a lobbying report for representation of University Hospitals Health System Inc. in Q42014 on Jan. 17, 2015.
Original Filing: 300699391.xml
Lobbying Issues
Inpatient hospital issues, including cancer care for patients, related to H.R. 83, the Consolidated & Further Continuing Appropriations Act of 2015; and the Hospital Improvements for Payment Act of 2014 (discussion draft).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, The D Major Group lobbied for University Hospitals Health System Inc. , earning $20,000. The report was filed on Oct. 10, 2014.
Original Filing: 300675312.xml
Lobbying Issues
Issues concerning Medicare prospective payment system, including advances in cancer care.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, The D Major Group lobbied for University Hospitals Health System Inc. , earning $10,000. The report was filed on July 18, 2014.
Original Filing: 300663024.xml
Lobbying Issues
Medicare hospital inpatient and outpatient issues, including cancer care services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2397, The Department of Defense Appropriations Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, The D Major Group lobbied for University Hospitals Health System Inc. , earning $10,000. The report was filed on April 17, 2014.
Original Filing: 300638383.xml
Lobbying Issues
Medicare hospital inpatient and outpatient issues, including cancer care services.
H.R. 4302, Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3547, Consolidated Appropriations Act of 2014
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, The D Major Group lobbied for University Hospitals Health System Inc. , earning $10,000. The report was filed on Jan. 18, 2014.
Original Filing: 300619928.xml
Lobbying Issues
Medicare hospital inpatient and outpatient issues, including cancer care services.
H.R. 2810, The Medicare Patient Access and Quality Improvement Act of 2013
The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 (Senate Finance)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.J. Res. 59, The Bipartisan Budget Act of 2013
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
The D Major Group filed a lobbying registration on Dec. 1, 2013 to represent University Hospitals Health System, Inc., effective Nov. 1, 2013.
Original Filing: 300610240.xml
Issue(s) they said they’d lobby about: Issues related to Medicare and Medicaid hospital funding, as well as the Affordable Care Act. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...